scholarly article | Q13442814 |
P50 | author | Marcio Nucci | Q37837344 |
M Garnica | Q57017191 | ||
P2093 | author name string | Arnaldo L Colombo | |
Luis Fernando Aranha Camargo | |||
Ana Lucia Senna | |||
Antonio Carlos Bandeira | |||
Clovis Arns Da Cunha | |||
Danielle Borghi | |||
Maria Eugenia Valias Didier | |||
Tatiana Campos | |||
Viviane Carvalho Dias | |||
P2860 | cites work | Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia. | Q32122087 |
Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry | Q33445758 | ||
Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study | Q33595137 | ||
Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods | Q33738435 | ||
Population ageing in developed and developing regions: implications for health policy | Q34022897 | ||
Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland | Q34194192 | ||
Variation in critical care services across North America and Western Europe | Q34819861 | ||
Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers | Q35073043 | ||
Epidemiology of opportunistic fungal infections in Latin America. | Q37775629 | ||
Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality. | Q39795440 | ||
Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program | Q43118426 | ||
Predictors of candidaemia caused by non-albicans Candida species: results of a population-based surveillance in Barcelona, Spain | Q43135266 | ||
Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death | Q43142736 | ||
Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). | Q46072663 | ||
Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in Brazil | Q46373998 | ||
Age as a basis for healthcare rationing. Support for agist policies. | Q53612482 | ||
P433 | issue | 1 | |
P921 | main subject | Candida glabrata | Q139137 |
emerging pathogen | Q108429945 | ||
P304 | page(s) | 38-44 | |
P577 | publication date | 2012-07-05 | |
P1433 | published in | Medical Mycology | Q6806389 |
P1476 | title | Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals | |
P478 | volume | 51 |
Q39684445 | Breakthrough candidemia due to multidrug-resistant Candida glabrata during prophylaxis with a low dose of micafungin. |
Q34492906 | Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris |
Q35903892 | Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program |
Q38711698 | Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus. |
Q92772855 | Epidemiology and prognostic factors of nosocomial candidemia in Northeast Brazil: A six-year retrospective study |
Q34635088 | Epidemiology of candidemia in Latin America: a laboratory-based survey |
Q53694044 | Evaluation of Candida bloodstream infection and antifungal utilization in a tertiary care hospital. |
Q35980145 | FREQUENCY OF Candida SPECIES IN A TERTIARY CARE HOSPITAL IN TRIANGULO MINEIRO, MINAS GERAIS STATE, BRAZIL. |
Q36503873 | First description of Candida nivariensis in Brazil: antifungal susceptibility profile and potential virulence attributes. |
Q47147760 | Identification and antifungal susceptibility of Candida species isolated from the urine of patients in a university hospital in Brazil. |
Q40703127 | Imbalanced Macrophage and Dendritic Cell Activations in Response to Candida albicans in a Murine Model of Diabetes Mellitus |
Q42252984 | Invasive candidosis: contrasting the perceptions of infectious disease physicians and intensive care physicians. |
Q30841261 | Nosocomial bloodstream Candida infections in a tertiary-care hospital in South Brazil: a 4-year survey |
Q46302196 | Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil. |
Q34252030 | Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period |
Q40090888 | Relationship between the Antifungal Susceptibility Profile and the Production of Virulence-Related Hydrolytic Enzymes in Brazilian Clinical Strains of Candida glabrata. |
Q48523172 | Revisiting Species Distribution and Antifungal Susceptibility of Candida Bloodstream Isolates from Latin American Medical Centers. |
Q41887639 | Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates |
Q34632356 | Trafficking of phagocytic peritoneal cells in hypoinsulinemic-hyperglycemic mice with systemic candidiasis |
Search more.